TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25360528

Group type: EXPERIMENTAL
Intervention: Glycerol-preserved graft
Number of subjects: 106

Group type: COMPARATOR
Intervention: Freeze-dried graft
Number of subjects: 106
Study: 23295777

Group type: EXPERIMENTAL
Intervention: Pre-alert dispatch workflow with Medical Priority Dispatch System
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard dispatch without pre-alert
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Pre-alert dispatch workflow with Medical Priority Dispatch System in critically ill patients
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard dispatch without pre-alert in critically ill patients
Number of subjects: 1500
Study: 21549292

Group type: EXPERIMENTAL
Intervention: Automated pressure change detection (PCD) algorithm using intracardiac pressures measured with an implantable hemodynamic monitor (IHM).
Number of subjects: 274

Group type: COMPARATOR
Intervention: Intracardiac pressures measured with IHM analyzed using PCD algorithm.
Number of subjects: 274
Study: 18817474

Group type: EXPERIMENTAL
Intervention: LLLT (655 nm) of 5 J at an energy density of 500 J/cm2 administered at four points along the biceps muscle belly
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo LLLT administered in the same manner
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: LLLT (655 nm)
Number of subjects: 12
Study: 16580286

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) followed by oral nifidepine tocolysis (n = 24)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No tocolysis (n = 30)
Number of subjects: 54
Study: 14558283

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10808210

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD) 2 mg/kg/day intravenously
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluconazole 200 mg/day orally
Number of subjects: 24
Study: 8827784

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) therapy for 1 week
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) therapy for 1 week (after discontinuation)
Number of subjects: 48
Study: 1306636

Group type: EXPERIMENTAL
Intervention: Beclomethasone Dipropionate per nasal spray (400 mcg a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Antihistaminical drugs or ketotifen per os and Disodium chromoglycate per nasal spray
Number of subjects: 20
Study: 3910116

Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted relaxation (BAR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 30178599

Group type: EXPERIMENTAL
Intervention: Controlled cord traction (n=150)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Manual removal
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Controlled cord traction
Number of subjects: 345
Study: 28196498

Group type: EXPERIMENTAL
Intervention: Family and home-related factors including cognitive variables (parental attitude, subjective norm), environmental variables (availability of SSB, parenting practices), and habitual variables (habit strength, taste preference)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Ethnic background of the child
Number of subjects: 644
Study: 24313250

Group type: EXPERIMENTAL
Intervention: T1 (thin, 2 mm or less)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: T2 (thin thickened with allogenic membrane)
Number of subjects: 97

Group type: COMPARATOR
Intervention: C (thick, more than 2 mm)
Number of subjects: 97
Study: 22743670

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) for 2 months
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sham CPAP for 2 months
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Obstructive Sleep Apnoea (OSA) patients
Number of subjects: 81
Study: 21177786

Group type: EXPERIMENTAL
Intervention: 12-week hypocaloric diet alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 12-week hypocaloric diet with aerobic exercise training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Weight maintenance after active weight loss
Number of subjects: 18
Study: 19520016

Group type: EXPERIMENTAL
Intervention: Educational intervention for GPs addressing knowledge, skills, and attitudes about first-episode psychosis
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control practices (no educational intervention)
Number of subjects: 179
Study: 17712157

Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation program
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Psychoeducational program
Number of subjects: 32
Study: 15358868

Group type: EXPERIMENTAL
Intervention: Visual search tasks in adults with autism
Number of subjects: 0
Study: 12351279

Group type: EXPERIMENTAL
Intervention: Oral desipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9893687

Group type: EXPERIMENTAL
Intervention: Magnification
Number of subjects: 52

Group type: COMPARATOR
Intervention: No magnification (Control)
Number of subjects: 52
Study: 8042723

Group type: EXPERIMENTAL
Intervention: Alfentanil on induction of anaesthesia (40 micrograms.kg‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alfentanil after the skin incision (40 micrograms.kg‐1)
Number of subjects: 40
Study: 3409432

Group type: EXPERIMENTAL
Intervention: Control blood glucose plus acupuncture
Number of subjects: 27

Group type: COMPARATOR
Intervention: Simple control blood glucose
Number of subjects: 27
Study: 30485612

Group type: EXPERIMENTAL
Intervention: heartfailurematters.org website
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: e-health adjusted care pathway
Number of subjects: 450

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 450
Study: 28341415

Group type: EXPERIMENTAL
Intervention: Diuretic strategy based on CA125: high dose if CA125 > 35 U/mL, low doses otherwise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard diuretic strategy: titration based on conventional clinical and biochemical evaluation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretic strategy based on CA125
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard diuretic strategy
Number of subjects: 0
Study: 25981372

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion at 4 kcal/min (ID4)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intraduodenal glucose infusion at 2 kcal/min (ID2)
Number of subjects: 19
Study: 23063790

Group type: EXPERIMENTAL
Intervention: Phonophoresis of piroxicam (PhP) with 4 grams of 0.5% piroxicam gel, 20mg of piroxicam drug, ultrasound program, continuous mode, 1.0W/cm(2), 10 minutes per session, 5 times per week for 2 weeks.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Ultrasound therapy (UT) using nondrug coupling gel, ultrasound program, continuous mode, 1.0W/cm(2), 10 minutes per session, 5 times per week for 2 weeks.
Number of subjects: 46
Study: 21750201

Group type: EXPERIMENTAL
Intervention: Cixutumumab (6 mg/kg IV) and Temsirolimus (25 mg IV)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cixutumumab alone or combined with Temsirolimus
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: FDG-PET/CT
Number of subjects: 42
Study: 18843280

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study: 16449096

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Phenobarbital
Number of subjects: 27
Study: 14708410

Group type: EXPERIMENTAL
Intervention: H2RA-based triple regimen (20 mg famotidine, 1.0 g amoxicillin, 0.4 g metronidazole) for 1 week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: H2RA-based triple regimen (20 mg famotidine, 1.0 g amoxicillin, 0.4 g metronidazole) for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: PPI-based triple regimen (20 mg omeprazole, 1.0 g amoxicillin, 0.4 g metronidazole) for 1 week
Number of subjects: 0

Group type: COMPARATOR
Intervention: PPI-based triple regimen (20 mg omeprazole, 1.0 g amoxicillin, 0.4 g metronidazole) for 2 weeks
Number of subjects: 0
Study: 10829335

Group type: EXPERIMENTAL
Intervention: 12-Step, Minnesota Model treatment (completed treatment)
Number of subjects: 245

Group type: COMPARATOR
Intervention: 12-Step, Minnesota Model treatment (incomplete treatment)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Waiting list group
Number of subjects: 245
Study: 9305460

Group type: EXPERIMENTAL
Intervention: lorazepam 2 mg
Number of subjects: 27
Study: 8321672

Group type: EXPERIMENTAL
Intervention: Topical application of essential oils of lavender species 1
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Topical application of essential oils of lavender species 2
Number of subjects: 28
Study: 2425156

Group type: EXPERIMENTAL
Intervention: Propranolol (0.15 mg/kg i.v.)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pindolol (0.02 mg/kg i.v.)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol and Pindolol (both drugs during exercise)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol and Pindolol (at equipotent dosages)
Number of subjects: 6
Study: 29996883

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Repeated non-surgical periodontal therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Standard-of-care and Repeated non-surgical periodontal therapy
Number of subjects: 72
Study: 27821313

Group type: EXPERIMENTAL
Intervention: Systematic early palliative care (EPC)
Number of subjects: 207

Group type: COMPARATOR
Intervention: On-demand early palliative care (EPC)
Number of subjects: 207
Study: 24345398

Group type: EXPERIMENTAL
Intervention: MDMA (100 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (ascorbic acid)
Number of subjects: 19
Study: 22745239

Group type: EXPERIMENTAL
Intervention: Synthetic human acyl ghrelin (0.2 or 0.6 nmol/kg · h)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 14
Study: 20149756

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 125

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 125
Study: 18307127

Group type: EXPERIMENTAL
Intervention: Electrical vestibular stimulation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Head rotation
Number of subjects: 2
Study: 16083703

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: IGF-I
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: IGF-I/IGFBP-3 ratio
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Visceral adipose tissue (VAT)
Number of subjects: 458
Study: 12746252

Group type: EXPERIMENTAL
Intervention: Pulmozyme
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal saline aerosol
Number of subjects: 25
Study: 10485385

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 8523302

Group type: EXPERIMENTAL
Intervention: Self-intermittent dilatation (SID) group
Number of subjects: 51

Group type: COMPARATOR
Intervention: No dilatation (non-SID) group
Number of subjects: 51
Study: 2201256

Group type: EXPERIMENTAL
Intervention: 1-hour infusion of amphotericin B (group A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 4-hour infusion of amphotericin B (group B)
Number of subjects: 12
Study: 6109538

Group type: EXPERIMENTAL
Intervention: Betaxolol 10 mg daily for 7 days
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Betaxolol 20 mg daily for 7 days
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Betaxolol increasing doses up to 60 mg/day for 15 days
Number of subjects: 2
Study: 31734213

Group type: EXPERIMENTAL
Intervention: CAD-RADS
Number of subjects: 3840

Group type: COMPARATOR
Intervention: Traditional stenosis-based assessments
Number of subjects: 3840
Study: 31574792

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (GCBT) for 8 consecutive weeks, 2.5-hour sessions each week
Number of subjects: 28

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 28
Study: 27518489

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 168

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 168

Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 168
Study: 26032174

Group type: EXPERIMENTAL
Intervention: Transparent simulator (Group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Non-transparent simulator (Group 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Verbal instruction only (Group 3)
Number of subjects: 36
Study: 23403768

Group type: EXPERIMENTAL
Intervention: Biatrial pacing (Group I)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Single atrial pacing (Group II)
Number of subjects: 240

Group type: COMPARATOR
Intervention: No pacing (Group III)
Number of subjects: 240
Study: 21489609

Group type: EXPERIMENTAL
Intervention: Ze 339
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: COMPARATOR
Intervention: Desloratadine
Number of subjects: 18
Study: 19181592

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.06 mg/kg as a priming dose
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.01 mg/kg as a priming dose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study: 17971314

Group type: EXPERIMENTAL
Intervention: Magnesium carbonate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 30
Study: 14747211

Group type: COMPARATOR
Intervention: Established plus DASH (Group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Advice only (Group A)
Number of subjects: 0
Study: 14725687

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg/orally, twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/orally, twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined metformin (850 mg/orally, twice daily) + flutamide (250 mg/orally, twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypocaloric diet alone
Number of subjects: 40
Study: 10506726

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 150 U/kg, 3 times per week; increased to 300 U/kg and 450 U/kg if nonresponsive
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no EPO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment group
Number of subjects: 30
Study: 7863986

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (n = 9)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (n = 10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (Resting conditions)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Atrial pacing
Number of subjects: 19
Study: 2382455

Group type: EXPERIMENTAL
Intervention: Savary-Gilliard dilators
Number of subjects: 60

Group type: COMPARATOR
Intervention: Balloon dilatation
Number of subjects: 60
Study: 6794938

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 27
Study: 31990246

Group type: EXPERIMENTAL
Intervention: Combination of vitamin C, thiamine and hydrocortisone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard therapy alone (control group)
Number of subjects: 100
Study: 30925157

Group type: EXPERIMENTAL
Intervention: CRADLE intervention (novel vital sign device and training package)
Number of subjects: 536233

Group type: COMPARATOR
Intervention: Magnesium sulfate availability
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Eclampsia cases
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Eclampsia, stroke, or hypertensive disorder of pregnancy causing intensive care admission or maternal death
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Eclampsia cases by age
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Rates of eclampsia
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: First eclamptic fits
Number of subjects: 536233
Study: 28193240

Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg/day) for 4 weeks instead of ethambutol
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg/day) for 2 weeks instead of ethambutol
Number of subjects: 429

Group type: COMPARATOR
Intervention: Standard treatment (isoniazid, rifampicin, pyrazinamide, and ethambutol)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Total adverse events (AEs) and serious AEs
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Sputum culture conversion rate on solid media after 2 months
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Time to sputum culture conversion on liquid and solid media
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Cure rate
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Treatment success rate
Number of subjects: 429
Study: 27101551

Group type: EXPERIMENTAL
Intervention: Admission pro-adrenomedullin (proADM)
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Admission pro-atrial natriuretic peptide (proANP)
Number of subjects: 753
Study: 24626264

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thoracentesis
Number of subjects: 160

Group type: COMPARATOR
Intervention: Thoracentesis without ultrasound guidance
Number of subjects: 160
Study: 22424813

Group type: EXPERIMENTAL
Intervention: Regular visits to a primary care provider (PCP) at least once per year
Number of subjects: 16893

Group type: COMPARATOR
Intervention: No regular visits to a primary care provider (PCP)
Number of subjects: 16893
Study: 19053944

Group type: EXPERIMENTAL
Intervention: Vitamin E (1000 i.u.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17202116

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Thyroid hormone replacement
Number of subjects: 73
Study: 16086931

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medications
Number of subjects: 11958
Study: 11981766

Group type: EXPERIMENTAL
Intervention: Transarterial Lipiodol chemoembolization (variable dose of cisplatin in Lipiodol and gelatin-sponge particles, median 4.5 courses per patient)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Symptomatic treatment (control group)
Number of subjects: 80
Study: 9818107

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine (8 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1% hyperbaric bupivacaine (8 mg)
Number of subjects: 60
Study: 7543348

Group type: EXPERIMENTAL
Intervention: Tenidap 120 mg/day (once daily)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Diclofenac 150 mg/day (50 mg t.i.d)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Tenidap
Number of subjects: 384

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 384
Study: 30926298

Group type: EXPERIMENTAL
Intervention: Cervarix® vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gardasil® vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-vaccine types
Number of subjects: 0
Study: 29962179

Group type: COMPARATOR
Intervention: High Intensity Resistance Training (HIRT) at 70% of One‐Repetition Maximum (1‐RM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low Intensity Resistance Training with Blood Flow Restriction (LIRT + BFR) at 30% of 1‐RM with BFR
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low Intensity Resistance Training (LIRT) at 30% of 1‐RM
Number of subjects: 18
Study: 27081856

Group type: EXPERIMENTAL
Intervention: Evaluation context (primed participants knew they were being evaluated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Directed Evaluation context (primed participants knew they were being evaluated and were instructed to make a positive impression)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control context (primed participants did not know they were being evaluated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Directed Evaluation context
Number of subjects: 0
Study: 25302637

Group type: EXPERIMENTAL
Intervention: Pea hull fibre (7 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pea protein (10 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pea protein (10 g) plus hull fibre (7 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Yellow peas (406 g)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (noodles and tomato sauce)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pea protein plus fibre
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Yellow peas
Number of subjects: 15
Study: 22172242

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 2201

Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 2201
Study: 19780738

Group type: COMPARATOR
Intervention: Doxycycline capsules 100 mg twice daily plus triple sulfa vaginal cream once daily for ten days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Doxycycline capsules 100 mg twice daily and triple sulfa vaginal cream once daily plus vitamin C tablets 250 mg once daily for ten days
Number of subjects: 80
Study: 17206698

Group type: EXPERIMENTAL
Intervention: Group-based intervention program consisting of nine weekly sessions, alternating lectures and group therapy sessions.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Group-based intervention program.
Number of subjects: 44
Study: 15315180

Group type: EXPERIMENTAL
Intervention: Propofol (6 mg/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane (1%-2%)
Number of subjects: 40
Study: 11317113

Group type: EXPERIMENTAL
Intervention: Aerobics
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Muscle training on devices
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 59
Study: 9257791

Group type: EXPERIMENTAL
Intervention: Grass pollen nasal challenge
Number of subjects: 21